Viewing Study NCT01098903



Ignite Creation Date: 2024-05-05 @ 10:22 PM
Last Modification Date: 2024-10-26 @ 10:18 AM
Study NCT ID: NCT01098903
Status: COMPLETED
Last Update Posted: 2012-07-12
First Post: 2010-03-16

Brief Title: Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA
Organization: Academisch Medisch Centrum - Universiteit van Amsterdam AMC-UvA

Study Overview

Official Title: Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib Sutent SU11248 in Patients With Cancer
Status: COMPLETED
Status Verified Date: 2012-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CLEARSUN
Brief Summary: Sunitinib is an anticancer drug but like most drugs the effect varies from person to person This is partly due to a variation in how well each person eradicates the drug from the body This can lead to toxicity if the drug is eliminated slowly Just as important is inadvertent underdosing in people who eliminate the drug quickly which may lead to a reduced anti-cancer effect The investigators group has developed a battery of tests that may measure how an individual clears a drug from their body The investigators intend to apply these tests to a group of patients taking sunitinib to see whether any test will help predict the level of sunitinib in the body and also the side effects If a test seems to be promising from this study it may be possible to do a simple test on patients before they receive sunitinib so the best dose is chosen The tests involve identifying the genes that are involved with drug elimination CYP3A ABCB1 ABCG2 OCT1 OATP as well as directly measuring elimination using marker drugs midazolam clearance and sestamibi liver clearance
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None